The chitosan/carboxymethyl cellulose/montmorillonite scaffolds incorporated with epigallocatechin-3-gallate-loaded chitosan microspheres for promoting osteogenesis of human umbilical cord-derived mesenchymal stem cell
نویسندگان
چکیده
Abstract Epigallocatechin-3-gallate (EGCG) is a plant-derived flavonoid compound with the ability to promote differentiation of human bone marrow-derived mesenchymal stem cells (MSCs) into osteoblasts. However, effect EGCG on osteogenic umbilical cord-derived (HUMSCs) rarely studied. Therefore, in this study, effects are studied HUMSCs by detecting cell proliferation, alkaline phosphatase (ALP) activity, calcium deposition and expression relevant markers. The results showed that can proliferation vitro at concentration 2.5–5.0 ?M. Unfortunately, easily metabolized during culture, which reduces its bioavailability. paper, EGCG-loaded microspheres (ECM) were prepared embedded chitosan/carboxymethyl cellulose/montmorillonite (CS/CMC/MMT) scaffolds form CS/CMC/MMT-ECM for improving bioavailability EGCG. cultured induce differentiation. scaffold continuously released up 22 days. In addition, osteoblast Taken together, present study suggested entrainment ECM CS/CMC/MMT was prospective scheme promotion HUMSCs. Graphical
منابع مشابه
Human umbilical cord blood-derived mesenchymal stem cell transplantation for the treatment of spinal cord injury
The aim of the present study was to investigate the effects of human umbilical cord blood-derived mesenchymal stem cell (HUCB-MSC) transplantation on the functional restoration of spinal cord injury (SCI). A total of 46 adult Wistar rats were randomly divided into three groups: Injury (n=15), control (n=15) and transplantation (n=16). A SCI model was established using the modified Allen's metho...
متن کاملA New Two Step Induction Protocol for Neural Differentiation of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells
Background: In this study, we examined a new two step induction protocol for improving the differentiation of human umbilical cord blood-derived mesenchymal stem cells into neural progenitor cells. Materials and Methods: Human umbilical cord blood-derived mesenchymal stem cells were first cultured in Dulbecco’s modified eagle medium supplemented with 10% fetal bovine serum in a humidified incu...
متن کاملPlatelet-derived Microparticles increase the Expression of hTERT Gene in Umbilical Cord Mesenchymal Stem Cells
Background: Mesenchymal stem cells have been widely considered in clinical researches because of their self-renewality and differentiation into various tissues. Nevertheless, their limited in vitro life span, which occurs only after several divisions, makes some changes in these cells, which affects all of their characteristics and remarkably reduces their application. In this study, the effect...
متن کاملP 82: The Transplantation of Human Umbilical Cord Mesenchymal Stem Cells in Neonatal Strokes
Brain injuries that caused by strokes (result of intra partum ischemia) are a frequent cause of prenatal mortality and morbidity with limited therapeutic options. Transplanting human mesenchymal stem cells (hmscs) indicates improvement in hypoxic Ischemic brain injury (HIBD) by secretion growth factor stimulating repair processes (Hmscs) known as multi potent cells which isolated from bone marr...
متن کاملHuman umbilical cord mesenchymal stem cell transplantation restores damaged ovaries
Ovarian injury because of chemotherapy can decrease the levels of sexual hormones and potentia generandi of patients, thereby greatly reducing quality of life. The goal of this study was to investigate which transplantation method for human umbilical cord mesenchymal stem cells (HUMSCs) can recover ovarian function that has been damaged by chemotherapy. A rat model of ovarian injury was establi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Bioresources and Bioprocessing
سال: 2022
ISSN: ['2197-4365']
DOI: https://doi.org/10.1186/s40643-022-00513-7